Tsuchiya T, Miyawaki S, Teranishi Y, Ohara K, Hirano Y, Ogawa S
Acta Neuropathol Commun. 2025; 13(1):24.
PMID: 39910685
PMC: 11796276.
DOI: 10.1186/s40478-025-01937-w.
Xu D, Yin S, Shu Y
NPJ Precis Oncol. 2024; 8(1):133.
PMID: 38879686
PMC: 11180135.
DOI: 10.1038/s41698-024-00627-5.
Kyrkou A, Valla R, Zhang Y, Ambrosi G, Laier S, Muller-Decker K
Nat Commun. 2024; 15(1):5115.
PMID: 38879607
PMC: 11180199.
DOI: 10.1038/s41467-024-49298-7.
Yuan R, Wang B, Wang Y, Liu P
Oncol Ther. 2024; 12(2):257-276.
PMID: 38760612
PMC: 11187037.
DOI: 10.1007/s40487-024-00279-2.
Hsieh A, Bi W, Ramesh V, Brastianos P, Plotkin S
Cancer. 2024; 130(15):2586-2600.
PMID: 38753473
PMC: 11260245.
DOI: 10.1002/cncr.35279.
Clinical and Genetic Correlation in Neurocristopathies: Bridging a Precision Medicine Gap.
Chatzi D, Kyriakoudi S, Dermitzakis I, Manthou M, Meditskou S, Theotokis P
J Clin Med. 2024; 13(8).
PMID: 38673496
PMC: 11050951.
DOI: 10.3390/jcm13082223.
Hippo pathway in intestinal diseases: focusing on ferroptosis.
Deng H, Jia Q, Ming X, Sun Y, Lu Y, Liu L
Front Cell Dev Biol. 2023; 11:1291686.
PMID: 38130953
PMC: 10734691.
DOI: 10.3389/fcell.2023.1291686.
Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.
Yuan J, Fu Y, Liu Y
Medicine (Baltimore). 2023; 102(50):e36696.
PMID: 38115252
PMC: 10727542.
DOI: 10.1097/MD.0000000000036696.
CD44 Intracellular Domain: A Long Tale of a Short Tail.
Skandalis S
Cancers (Basel). 2023; 15(20).
PMID: 37894408
PMC: 10605500.
DOI: 10.3390/cancers15205041.
Plasmodium falciparum exploits CD44 as a coreceptor for erythrocyte invasion.
Baro B, Kim C, Lin C, Kongsomboonvech A, Tetard M, Peterson N
Blood. 2023; 142(23):2016-2028.
PMID: 37832027
PMC: 10783654.
DOI: 10.1182/blood.2023020831.
YAP at the Crossroads of Biomechanics and Drug Resistance in Human Cancer.
Huang M, Wang H, Mackey C, Chung M, Guan J, Zheng G
Int J Mol Sci. 2023; 24(15).
PMID: 37569866
PMC: 10419175.
DOI: 10.3390/ijms241512491.
Lipid kinase PIP5Kα contributes to Hippo pathway activation via interaction with Merlin and by mediating plasma membrane targeting of LATS1.
Le T, Nguyen N, Le D, Anwar M, Lee S
Cell Commun Signal. 2023; 21(1):149.
PMID: 37337213
PMC: 10278285.
DOI: 10.1186/s12964-023-01161-w.
The clinical, genetic, and immune landscape of meningioma in patients with NF2-schwannomatosis.
Gregory G, Islim A, Hannan C, Jones A, Hammerbeck-Ward C, Rutherford S
Neurooncol Adv. 2023; 5(Suppl 1):i94-i104.
PMID: 37287576
PMC: 10243851.
DOI: 10.1093/noajnl/vdac127.
Missense variant interaction scanning reveals a critical role of the FERM domain for tumor suppressor protein NF2 conformation and function.
Moesslacher C, Auernig E, Woodsmith J, Feichtner A, Jany-Luig E, Jehle S
Life Sci Alliance. 2023; 6(8).
PMID: 37280085
PMC: 10244618.
DOI: 10.26508/lsa.202302043.
The genetic landscape and possible therapeutics of neurofibromatosis type 2.
Ghalavand M, Asghari A, Farhadi M, Taghizadeh-Hesary F, Garshasbi M, Falah M
Cancer Cell Int. 2023; 23(1):99.
PMID: 37217995
PMC: 10204202.
DOI: 10.1186/s12935-023-02940-8.
Deletion of Inhibits Metastasis Formation of Liver Cancer in -Mutant Mice.
Gerardo-Ramirez M, Giam V, Becker D, Groth M, Hartmann N, Morrison H
Cells. 2023; 12(9).
PMID: 37174657
PMC: 10177437.
DOI: 10.3390/cells12091257.
PLPP/CIN-mediated NF2 S10 dephosphorylation distinctly regulates kainate-induced seizure susceptibility and neuronal death through PAK1-NF-κB-COX-2-PTGES2 signaling pathway.
Kim J, Lee D, Kim T, Park H, Kim M, Kang T
J Neuroinflammation. 2023; 20(1):99.
PMID: 37118736
PMC: 10141957.
DOI: 10.1186/s12974-023-02788-9.
Merlin tumor suppressor function is regulated by PIP2-mediated dimerization.
Hennigan R, Thomson C, Stachowski K, Nassar N, Ratner N
PLoS One. 2023; 18(2):e0281876.
PMID: 36809290
PMC: 9942953.
DOI: 10.1371/journal.pone.0281876.
YAP/TAZ activation predicts clinical outcomes in mesothelioma and is conserved in in vitro model of driver mutations.
Cunningham R, Jia S, Purohit K, Salem O, Hui N, Lin Y
Clin Transl Med. 2023; 13(2):e1190.
PMID: 36740402
PMC: 9899629.
DOI: 10.1002/ctm2.1190.
Tumor Biology and Microenvironment of Vestibular Schwannoma-Relation to Tumor Growth and Hearing Loss.
Tesarova M, Peterkova L, Stastna M, Kolar M, Lacina L, Smetana Jr K
Biomedicines. 2023; 11(1).
PMID: 36672540
PMC: 9856152.
DOI: 10.3390/biomedicines11010032.